Prestige Invests $152m To Build Landmark R&D Center In South Korea

Prestige BioPharma has announced a memorandum of understanding with the city of Busan, in South Korea, to build a 45,000 sq m R&D center, including to “accelerate the development of innovative antibody drugs.”